Drug transfer into target helminth parasites

Area of Science:

• Pharmacology
• Parasitology
• Drug Discovery

Background:

• Anthelmintic drug pharmacokinetics govern drug concentration at the parasite site.
• Optimal anthelmintic action requires drug access to parasite-specific receptors.
• Drug entry and accumulation in helminths are critical for efficacy.

Purpose of the Study:

• To discuss passive drug transfer into helminths as a key factor in anthelmintic efficacy.
• To highlight the role of lipophilicity in anthelmintic drug penetration into parasites.
• To underscore the importance of understanding drug transfer mechanisms for parasite control.

Main Methods:

• Review of existing literature on anthelmintic pharmacokinetics and helminth drug entry.
• Analysis of physicochemical properties, specifically lipophilicity, influencing drug penetration.
• Comparison of drug entry mechanisms across different helminth types (nematodes, cestodes, trematodes).

Main Results:

• Passive drug transfer across the helminth external surface is the primary entry route for most anthelmintics.
• Lipophilicity is the major physicochemical determinant for anthelmintic drug entry and accumulation in target parasites.
• Despite structural differences (cuticle vs. tegument), lipophilicity governs drug entrance in nematodes, cestodes, and trematodes.

Conclusions:

• Understanding drug transfer into helminths is crucial for optimizing anthelmintic therapy.
• Lipophilicity is a key target for designing more effective anthelmintic drugs.
• Improved knowledge of these processes will enhance parasite control in human and veterinary medicine.